Clinical Ink is the leading provider of eSource solutions for the global clinical trials market. Founded in 2007, Clinical Ink is dedicated to transforming clinical development – from Start to Submit™ – by creating a completely paperless clinical trial platform for sites, sponsors, CROs and patients. Clinical Ink’s SureSource platform is purpose-built to capture eSource data ad documents electronically at the site, while the CentrosHealth patient engagement platform provides patients with a variety of configurable apps to keep them informed, involved and compliant throughout the duration of a clinical trial. Clinical Ink maintains offices in Winston-Salem, NC, Philadelphia, PA and Cambridge, MA. Additional information is available online at or toll-free 1-800-301-5033. Our customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. SureSource has been successfully used in a wide range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.
Winston-Salem, US
93 (est)-1%

Key People at Clinical

Edward S. Seguine

Edward S. Seguine

Doug Pierce

Doug Pierce


Clinical Locations

Winston-Salem, US
Cary, US
Horsham, US
Cambridge, US

Clinical Metrics

Clinical Summary

Founding Date


Total Funding

$24.3 M

Latest funding size

$24.3 M

Time since last funding

9 months

Clinical Online Presence

Clinical News

Clinical Company Life